Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
We compare which high yield ETF is tax efficient for retirement, highlighting tax considerations, holdings, and strategies to maximize after-tax income.
27,092 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Crypto executives and bank regulators left Washington with a shared sense that the work is far from over. The third W...
Democratic lawmakers are pushing the DOJ to reopen or strengthen antitrust scrutiny of the $1.6 billion Compass-Anywh...
Opendoor Technologies reports a sharp uptick in iBuying activity, with 1,706 homes bought in the latest quarter, lift...
Milan rolls out a modern Olympic stadium and hundreds of new homes, a move officials say primes the city for sustaine...
Atlassian Corp. PLC posted stronger-than-expected Q1 results, but its stock has still tumbled. With 25 analysts stick...
Urban Outfitters posted a strong Q4 2026 with record revenue, led by a rebound in its flagship Urban Outfitters brand...
SoundHound AI releases its latest quarterly results, prompting a brisk market response as investors weigh growth pros...
Berkshire Hathaway reduced its cash hoard to $373.3 billion by year-end 2025, a 2.1% drop from September, as Greg Abe...
As the 2026 market landscape bifurcates, Walmart emerges as a potential hedge, supported by strong Q4 results, expand...
Solana SOL bounced back above a critical level as Bitcoin steadies, reviving a solana price prediction: just debate a...
Midweek markets staged a notable reversal as Nasdaq-led tech names helped spark a Wednesday comeback. This guide expl...